R. A. Noble

发表

Inhibition of monocarboxylate transporter 1 by AZD3965 as a therapeutic approach in oncology

R. A. Noble, 2017 .

Simultaneous targeting of glycolysis and oxidative phosphorylation as a therapeutic strategy to treat diffuse large B-cell lymphoma

I. Dragoni, H. Keun, S. Wedge, 2022, British journal of cancer.

Inhibition of monocarboxylate transporter 1 by AZD 3965 as a novel therapeutic approach for the treatment of diffuse large B-cell lymphoma and Burkitt lymphoma

H. Keun, S. Wedge, V. Rand, 2017 .

Highly Potent Clickable Probe for Cellular Imaging of MDM2 and Assessing Dynamic Responses to MDM2-p53 Inhibition.

J. Lunec, J. Castro, S. Wedge, 2018, Bioconjugate chemistry.

Parallel Optimization of Potency and Pharmacokinetics Leading to the Discovery of a Pyrrole Carboxamide ERK5 Kinase Domain Inhibitor

M. Noble, J. Endicott, S. Cook, 2022, Journal of medicinal chemistry.

Simultaneous targeting of glycolysis and oxidative phosphorylation as a therapeutic strategy to treat diffuse large B-cell lymphoma

I. Dragoni, H. Keun, S. Wedge, 2022, British Journal of Cancer.

Inhibition of monocarboxyate transporter 1 by AZD3965 as a novel therapeutic approach for diffuse large B-cell lymphoma and Burkitt lymphoma

H. Keun, S. Wedge, V. Rand, 2017, Haematologica.

Modulation of ERK5 Activity as a Therapeutic Anti-Cancer Strategy.

S. Wedge, Duncan C Miller, S. Harnor, 2023, Journal of medicinal chemistry.